Nicolas Scheyer, MD

Département d’Endocrinologie, Diabétologie et Nutrition, CHRU de Nancy, Hôpital Brabois et Université de Lorraine
Vandœuvre-lès-Nancy, France

Disclosure information not submitted.

Presentation(s):

• SAT-013 - LINC 6 Ad Hoc Analysis of New Osilodrostat Users: Improvements in Quality of Life in Patients with Cushing'S Syndrome

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SAT-036 - Osilodrostat Treatment Outcomes Across Various Etiologies and Severities of Cushing'S Syndrome: LINC 7 Secondary Analysis

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT